KURE KraneShares MSCI All China Health Care Index ETF
Company Analysis
Latest News
🔴 KURE is trading 3.15% down today as Hong Kong CRO stocks slide
KURE is trading 3.15% down at $17.53 as Chinese healthcare shares and broader Chinese equities come under pressure. - On October 22, Hong Kong-listed CRO...
🟢 KURE is trading 3.29% up
KURE is trading at $18.23, up 3.29%; no clear company-specific announcement or verified catalyst for its October 20 move surfaced in available search...
🔴 KURE is trading 3.1% down amid Chinese healthcare-sector weakness
KURE is trading at $18.52 (-3.09%) amid weakness in Chinese healthcare shares. - On October 8, Chinese medical-equipment shares were notably lower. - Reports...
🟢 KURE is trading 3.77% up today amid broad China biotech and healthcare gains
KURE is trading at $19.50, up 3.77% on September 30 amid broad China biotech and healthcare ETF gains; no KURE-specific announcement surfaced. - In Hong Kong,...
🔴 KURE is trading 3.05% down today as 10-year Treasury yields reach 5.14%
KURE is trading 3.05% lower at $18.44, with the decline appearing tied mainly to broader risk-off conditions affecting equities and China-linked assets. - The...
🟢 KURE is trading 4.4% up today as easing inflation concerns support China-linked assets
KURE is trading at $19.18 (+4.44%) amid a broad risk-on session, with easing inflation concerns supporting China-linked assets. - The S&P 500, Nasdaq, and Dow...
🟢 KURE is trading 3.14% up today amid broader risk-on sentiment
KURE is trading at $18.40, up 3.14%, likely supported by broader market strength, with no clear company-specific announcement identified for September 17,...
🟢 KURE is trading 3.04% up despite broader U.S. weakness
KURE is trading at $18.28, up 3.04%, despite broader U.S. weakness. - The S&P 500 is down 0.48%, while the Nasdaq is down 0.65%. - No reliable...
🔴 KURE is trading 3.02% down today as Brent crude surpasses $100
KURE is trading 3.02% down at $18.16 amid broad risk-off pressure as Brent crude surpassed $100 per barrel following U.S.-Iran military escalation. - The Dow...
Kura Oncology Lands $10.9 Million Investment, Following CEO Share Purchase
Connor Clark & Lunn Investment Management Ltd. established a new position in Kura Oncology by purchasing 996,114 shares. This investment is valued at...